Showing results (1-10 of 185) with videos related to
Sort By:
Pageof 19
Journal of Immunological Methods|December 20, 1989
High-level expression of chimeric antibodies using adapted cDNA variable region cassettesS D Gillies, K M Lo, J WesolowskiCancer Research|May 8, 1999
Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptorsS D Gillies, Y Lan, K M Lo, et al.Biochimica Et Biophysica Acta|February 16, 1991
High level expression of human proteins in murine hybridoma cells: induction by methotrexate in the absence of gene amplificationK M Lo, S D GilliesGene|November 16, 1992
The use of a wild-type dihydrofolate reductase-encoding cDNA as a dominant selectable marker and induction of expression by methotrexateK M Lo, C A Lynch, S D GilliesJournal of Immunology (Baltimore, Md. : 1950)|February 1, 1991
Targeting human cytotoxic T lymphocytes to kill heterologous epidermal growth factor receptor-bearing tumor cells. Tumor-infiltrating lymphocyte/hormone receptor/recombinant antibodyS D Gillies, J S Wesolowski, K M LoBioconjugate Chemistry|May 1, 1993
Biological activity and in vivo clearance of antitumor antibody/cytokine fusion proteinsS D Gillies, D Young, K M Lo, et al.Proceedings of the National Academy of Sciences of the United States of America|February 15, 1992
Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cellsS D Gillies, E B Reilly, K M Lo, et al.Human Antibodies and Hybridomas|July 1, 1992
Expression and secretion of an assembled tetrameric CH2-deleted antibody in E. coliK M Lo, A Roy, S F Foley, et al.Hybridoma|June 1, 1991
Expression of genetically engineered immunoconjugates of lymphotoxin and a chimeric anti-ganglioside GD2 antibodyS D Gillies, D Young, K M Lo, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 24, 1998
Antibody-IL-12 fusion proteins are effective in SCID mouse models of prostate and colon carcinoma metastasesS D Gillies, Y Lan, J S Wesolowski, et al.Pageof 19